Newland Pharmaceuticals Co., Ltd. logo

Newland Pharmaceuticals Co., Ltd. (301277)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
10. 76
+0.01
+0.093%
¥
4.77B Market Cap
- P/E Ratio
1.14% Div Yield
7.44M Volume
- Eps
¥ 10.75
Previous Close
Add Transaction
Day Range
10.61 10.96
Year Range
8.45 15.7
Want to track 301277 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

301277 closed today higher at ¥10.76, an increase of 0.093% from yesterday's close, completing a monthly increase of 21.8573% or ¥1.93. Over the past 12 months, 301277 stock lost -8.5034%.
301277 is not paying dividends to its shareholders.
Newland Pharmaceuticals Co., Ltd. has completed 3 stock splits, with the recent split occurring on Apr 16, 2025.
The company's stock is traded on one exchange.

301277 Chart

People also search for

Dr Corp Ltd.
¥ 23.35
-2.4237%
Sunvim Group Co., Ltd.
¥ 11.72
-3.3003%
Tibet Gaozheng Explosive Co., Ltd.
¥ 58.61
-1.6281%
Innovative Medical Management Co., Ltd.
¥ 21.24
-3.1022%
Henan Liliang Diamond Co., Ltd.
¥ 59.21
-1.366%

Newland Pharmaceuticals Co., Ltd. (301277) FAQ

What is the stock price today?

The current price is ¥10.76.

On which exchange is it traded?

Newland Pharmaceuticals Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 301277.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.14%.

What is its market cap?

As of today, the market cap is 4.77B.

Has Newland Pharmaceuticals Co., Ltd. ever had a stock split?

Newland Pharmaceuticals Co., Ltd. had 3 splits and the recent split was on Apr 16, 2025.

Newland Pharmaceuticals Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Luwei Zhang CEO
XSHE Exchange
CNE1000065K2 ISIN
CN Country
1,042 Employees
30 Apr 2026 Last Dividend
16 Apr 2025 Last Split
- IPO Date

Overview

Newland Pharmaceutical Co., Ltd. specializes in the research, development, production, and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) within China's pharmaceutical sector. Initially established as Henan Newland Pharmaceutical Co., Ltd., the company underwent a name change in June 2023 to better reflect its expanding scope and capabilities. Founded in 2005 and situated in Changge City, China, Newland Pharmaceutical Co., Ltd. represents a significant player in the pharmaceutical manufacturing industry, leveraging its extensive expertise to cater to the growing demands of both domestic and potential international markets.

Products and Services

Newland Pharmaceutical Co., Ltd. offers an extensive range of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), each playing a crucial role in the development and manufacturing of various medical treatments:

  • Ropivacaine Hydrochloride: A local anesthetic used in regional anesthesia for surgery, postoperative pain management, and obstetrical procedures.
  • Naphazoline Hydrochloride: This compound is commonly used in ophthalmic solutions to relieve redness in the eyes caused by minor irritations.
  • Moxifloxacin Hydrochloride: An antibiotic belonging to the fluoroquinolone class, effective against a wide range of bacterial infections.
  • Lidocaine Hydrochloride: Employed as a local anesthetic and antiarrhythmic drug, it helps numb tissues in specific areas and treats certain types of heart arrhythmias.
  • Vildagliptin: An antidiabetic drug that is part of the dipeptidyl peptidase-4 (DPP-4) inhibitor class, used for the treatment of type 2 diabetes.
  • Tadalafil: Known for treating erectile dysfunction and symptoms of benign prostatic hypertrophy by relaxing muscles and increasing blood flow.
  • Chlorpheniramine Maleate: An antihistamine used to relieve symptoms of allergy, hay fever, and the common cold.
  • Clopidogrel Bisulfate: A medication that prevents stroke and heart attacks in persons at high risk by inhibiting platelets.
  • Lidocaine: Similar to Lidocaine Hydrochloride but often used in different formulations for numbing and antiarrhythmic purposes.
  • Febuxostat: Prescribed for the management of gout, Febuxostat works by reducing uric acid production in the body.
  • Esomeprazole Sodium and Esomeprazole Magnesium: Both forms of Esomeprazole, a proton pump inhibitor used to treat conditions such as gastroesophageal reflux disease (GERD), play a vital role in managing acidity-related disorders.

Contact Information

Address: East side of the southern section of Weiwu Road, Changge, China, 461500
Phone: 86 37 4610 5083